Green Cross Medical Science Corporation (142280) — Cash Flow Reinvestment Rate
Green Cross Medical Science Corporation (142280) has a Cash Flow Reinvestment Rate of 0.09x as of December 2025, reinvesting ₩460.89 Million (capex ₩460.89 Million ) from operating cash flow of ₩5.01 Billion. Explore Green Cross Medical Science Corporation capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Green Cross Medical Science Corporation Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Green Cross Medical Science Corporation across 6 annual periods. Also explore 142280 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Green Cross Medical Science Corporation (2016–2025)
Year-by-year capital reinvestment analysis for Green Cross Medical Science Corporation. For live market cap and broader valuation context, see how much is Green Cross Medical Science Corporation worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | ₩4.90 Billion | ₩7.20 Billion | ₩4.90 Billion | ▼ -61.5% |
| 2024 | 1.77x | ₩6.47 Billion | ₩3.66 Billion | ₩3.22 Billion | ▼ -20.7% |
| 2023 | 2.23x | ₩9.45 Billion | ₩4.24 Billion | ₩5.63 Billion | ▲ +311.2% |
| 2022 | 0.54x | ₩5.90 Billion | ₩10.88 Billion | ₩3.43 Billion | ▼ -0.8% |
| 2017 | 0.55x | ₩1.70 Billion | ₩3.11 Billion | ₩1.11 Billion | ▲ +106.8% |
| 2016 | 0.26x | ₩2.71 Billion | ₩10.25 Billion | ₩1.89 Billion | — |